Glycomimetics (GLYC) PT Lowered to $15 at Jefferies; Reiterates Buy

November 9, 2017 8:55 AM

Jefferies lowered its price target on Glycomimetics (NASDAQ: GLYC) to $15.00 (from $16.00) while maintaining a Buy rating following the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found